Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells

被引:7
|
作者
Klaihmon, Phatchanat [1 ]
Kang, Xing [1 ]
Issaragrisil, Surapol [1 ,2 ,3 ]
Luanpitpong, Sudjit [1 ,4 ]
机构
[1] Mahidol Univ, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Siriraj Hosp, Bangkok 10700, Thailand
[2] Mahidol Univ, Fac Med, Dept Med, Div Hematol,Siriraj Hosp, Bangkok 10700, Thailand
[3] Wattanosoth Canc Hosp, BDMS Ctr Excellence Hematol, Bangkok 10310, Thailand
[4] Mahidol Univ, Fac Med, Blood Prod & Cellular Immunotherapy Res Grp, Siriraj Hosp, Bangkok 10700, Thailand
关键词
chimeric antigen receptor; induced pluripotent stem cell; natural killer cell; anti-CD19; CAR; leukemia; CAR-NK; NK differentiation; DIFFERENTIATION; CANCER; MEMORY;
D O I
10.3390/ijms241310508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Natural killer (NK) cells are a part of innate immunity that can be activated rapidly in response to malignant transformed cells without prior sensitization. Engineering NK cells to express chimeric antigen receptors (CARs) allows them to be directed against corresponding target tumor antigens. CAR-NK cells are regarded as a promising candidate for cellular immunotherapy alternatives to conventional CAR-T cells, due to the relatively low risk of graft-versus-host disease and safer clinical profile. Human induced pluripotent stem cells (iPSCs) are a promising renewable cell source of clinical NK cells. In the present study, we successfully introduced a third-generation CAR targeting CD19, which was validated to have effective signaling domains suitable for NK cells, into umbilical cord blood NK-derived iPSCs, followed by a single-cell clone selection and thorough iPSC characterization. The established single-cell clone of CAR19-NK/iPSCs, which is highly desirable for clinical application, can be differentiated using serum- and feeder-free protocols into functional CAR19-iNK-like cells with improved anti-tumor activity against CD19-positive hematologic cancer cells when compared with wild-type (WT)-iNK-like cells. With the feasibility of being an alternative source for off-the-shelf CAR-NK cells, a library of single-cell clones of CAR-engineered NK/iPSCs targeting different tumor antigens may be created for future clinical application.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
    Luanpitpong, Sudjit
    Poohadsuan, Jirarat
    Klaihmon, Phatchanat
    Issaragrisil, Surapol
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [2] Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
    Phatchanat Klaihmon
    Sudjit Luanpitpong
    Xing Kang
    Surapol Issaragrisil
    Cancer Cell International, 23
  • [3] Functional Chimeric Antigen Receptor-Expressing Natural Killer Cells Derived From Human Pluripotent Stem Cells
    Hermanson, David L.
    Ni, Zhenya
    Knorr, David A.
    Bendzick, Laura
    Pribyl, Lee J.
    Geller, Melissa
    Kaufman, Dan S.
    BLOOD, 2013, 122 (21)
  • [4] Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
    Klaihmon, Phatchanat
    Luanpitpong, Sudjit
    Kang, Xing
    Issaragrisil, Surapol
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [5] The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells
    Moscarelli, Jake
    Zahavi, David
    Maynard, Rachael
    Weiner, Louis M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 650 - 656
  • [6] Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy
    Zhao, Yu
    Zhou, Xiaorong
    IMMUNOTHERAPY, 2020, 12 (09) : 653 - 664
  • [7] Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy
    Habib, Sana
    Tariq, Syed M.
    Tariq, Moeez
    OCHSNER JOURNAL, 2019, 19 (03): : 186 - 187
  • [8] Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells
    Mirzaei, Hamid Reza
    Jamali, Arezoo
    Jafarzadeh, Leila
    Masoumi, Elham
    Alishah, Khadijeh
    Mehrjardi, Keyvan Fallah
    Emami, Seyed Amir Hossein
    Noorbakhsh, Farshid
    Till, Brian G.
    Hadjati, Jamshid
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 9207 - 9215
  • [9] Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
    Dai, Kai
    Wu, Yin
    She, Sha
    Zhang, Qian
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (12) : 2029 - 2037
  • [10] Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
    Kai Dai
    Yin Wu
    Sha She
    Qian Zhang
    World Journal of Gastrointestinal Oncology, 2021, (12) : 2029 - 2037